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Abstract We have isolated a cDNA coding for a delayed recti- 
fier K ÷ channel (RBKV1.5) from rabbit heart. The amino acid 
sequence of RBKV1.5 displays a homology to that of other K ÷ 
channels of Kvl.5 class. Overall amino acid identity between 
RBKV1.5 channel and Kvl.5 channel of other species is about 
85%. RNA blot analysis revealed the expression of the primary 
transcript in various rabbit tissues, at the highest level in both the 
atrium and ventricle. When expressed in Xenopus oocytes, 
RBKV1.5 current showed a delayed rectifier type characteristics, 
which was converted to rapidly inactivating currents upon coex- 
pression with a/3 snbunit. 
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K + channel fl subunits are thought to increase the complexity 
and the diversity of voltage-dependent Kvl  channels. 
It is obvious that careful comparison of the properties of any 
cloned channel and the native channel is necessary to evaluate 
the physiological importance of the results obtained from the 
cloned channel. Therefore, we must have both cloned channels 
and native channels of easily obtainable animal cells from the 
same species to compare the two systems. Rabbit heart may be 
a suitable preparation because the types and sizes of ionic 
currents in rabbit atrium are known to be very similar to those 
in human atrium. In the present study we show the cloning a 
voltage-dependent K + channel from rabbit heart and the influ- 
ence of rat fl subunit on the currents flowing through the K + 
channel, 
1. Introduction 2. Materials and methods 
Voltage-dependent K ÷ channels play important roles in car- 
diac excitability as they contribute to the various repolarization 
phases of the action potential. They form the most diversified 
class of ion channels and at present at least six different voltage- 
dependent K + currents have been described in mammalian 
heart [1-6]. In order to study the current of interest, such 
techniques as ion substitution and pharmacological dissection 
have been used to eliminate the overlapping currents, However, 
it is not easy to isolate and characterize the current of interest 
because the overlapping currents have similar sensitivities to 
pharmacological gents and the changes in its kinetics may be 
due to ion substitution. Another attempt o isolate the individ- 
ual channel components has been made by molecular biological 
approach. Several voltage-dependent K ÷channel clones (pore- 
forming ~ subunits) have been isolated from the heart of vari- 
ous species including human [7-10]. In addition to ~ subunits, 
two fl subunits (Kvfll and Kvfl2) of Shaker-related Kvl  chan- 
nel family have recently been cloned from rat brain [11]. Kvfll 
is reported to convert a delayed rectifier type K + channel 
(Kvl. 1) into a rapidly inactivating A-type channel and to accel- 
erate the inactivation of an A-type channel (Kvl.4) upon co- 
expression [11]. Very recently a third type of K + channel fl 
subunits (Kvfl3) has been cloned from human atrium, which 
modulates the kinetics of some Kvl  type channels [12]. These 
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The nucleotide sequence data of RBKV1.5 will appear in the GSDB, 
DDBJ, EMBL and NCBI nueleotide sequence databases with the fol- 
lowing accession umber D45025. 
2.1. eDNA cloning and sequencing 
Rabbit heart cDNA library was constructed in 2GEM2 (Promega) 
according to the standard methods [14]. A KpnI-PstI-digested fragment 
of rat Kvl.2 [15] was labeled with 32p by the random priming method 
and used to screen the cDNA library. Approximately 6.0 × 105 plaques 
were screened under low stringency conditions and 11 positive clones 
were isolated, The eDNA inserts were subcloned into EcoRI site of 
pBluescript SK(+) vector (Stratagene). We selected one clone 
(RBKVI.5) containing the longest insert (2.7 kb) for further character- 
ization. DNA sequencing of RBKV1.5 was performed on both strands 
by the dideoxy chain termination method using A.L.E DNA Sequencer 
II (Pharmacia). 
Polymerase chain reaction (PCR) was used to obtain rat Kvfll. Two 
oligonucleotide primers were synthesized according to non-coding re- 
gion of Kvfll mRNA [11]. The sense primer corresponded to nucle- 
otides -160 to -141 and the antisense primer corresponded to nucle- 
otides 1346-1365 (the first residue of the initiating ATG is number 1). 
The 5' part of both primers was designed to contain EcoRI site to 
facilitate subcloning. PCR was carried out using rat brain cDNA as a 
template under the following conditions: 94°C, I min; 54°C, 2 min; 
72°C, 3 min for 30 cycles. The amplified products were digested with 
EeoR! and subcloned into pBluescript SK(+) vector (Stratagene). DNA 
sequencing confirmed the PCR clone as Kvfll. 
2.2. RNA blot analys& 
Total RNAs were isolated from various tissues by the guanidinium 
thiocyanate method and poly(A) ÷ RNAs were purified using mRNA 
Purification Kit (Pharmacia). Five/~g poly(A) ÷ RNAs from each tissue 
were electrophoresed on 1% agarose gel containing formaldehyde and 
transferred by capillary action to GeneScreen Plus membrane (NEN). 
A 2.7 kb fragment specific for RBKV1.5 and 0.5 kb fragment specific 
for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were used as 
hybridization probes. The probes were labeled by 32p using BcaBEST 
Labeling Kit (Takara). The filter was hybridized for 24 h in 50% forma- 
mide, 5 × SSPE, 0.1% SDS, 5 × Denhardt's olution and 200/~g/ml 
herring testis DNA at 42°C. The filter was briefly washed with 
0.2 × SSC/0.1% SDS at room temperature, followed by two 15-min 
washes with 0.2 × SSC/0.1% SDS at 65°C. Autoradiography was per- 
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formed on Kodak X-AR film for 88 h at -80°C with an intensifying 
screen. 
2.3. Functional expression in Xenopus oocytes 
Electrophysiological measurements were carried out essentially the 
same as those reported previously [15]. The plasmid containing 
RBKV1.5 or KvB1 was linearized by digestion with appropriate restric- 
tion enzyme and capped run-off cRNA was synthesized in vitro with 
T7 RNA polymerase (Stratagene). Transcribed RNAs were dissolved 
in water at a final concentration of 0.2 pg/pl for oocyte injection. When 
cRNAs specific for RBKV1.5 and Kvfll were mixed; weight ratio of 
1 : 1 was employed. Xenopus laevis oocytes (stage V and VI) were treated 
for 2 h with collagenase (2 mg/ml; Wako) in modified Barth's medium 
RBKVI .5  1 MEIALGPLENGGAMTIRGGGEETAGCS QAA P TAGLGDGSQEPAPRGR 47 
HK2 1 . . . .  V . . . . . . .  V -  -D -AR- -  G - TGGELQC-P  - - -S  -PK  . . . .  K - 54 
Kvl 1 - - -S -V -  - -  S -L  . . . . . .  A CV-TPRGECGC-P -S  -NNQ-K-TLL -  54 
mKv l .5  1 - - -S -V -T - -  S - - -L  . . . .  AV-S -V  -SPRGECGC-P - -  -MNQ-K-TS  - 53 
cKv l .5  1 - -L - -V  . . . . . . .  V . . . .  AR- - -G  - -VGGELQC-  - -AR-A  PK-RE- -E -  53 
48  GCS ARRGA EP  GERPLPP  QP  P E LPQSRR SPLE  E E 80  
55  -Q-D DS V . . . .  L -D  GVRPLPPLPEE- -RP-  P -P -D-  96  
55  TTLED-NQ . . . . .  MA . . . .  P -  L -A  D - 85  
54  - -TH-DAAQ G- - -  M Q - - -P - -  SA  D-  85  
54  -PP  - - -D  - -A  . . . .  A L . . . .  L PG D - 80 
g l  EGEGDP GLS VAEE QTLG A GA L HHQRVL IN ISGLRPETQLGTLAQF 125 
97  . . . . . .  GT-  -D  -A - -  T -S  . . . . . .  H . . . . . . . . . . . .  140  
86  . . . . . . .  GT-  - -D -APQD-  S . . . . . . . . . . . . . . . . . . . .  132  
86  . . . . . .  GT-  -D-  PQDS-S  . . . . . . . . . . . . .  D - -V - -  132  
81  - -D- - -RL - -  -D  CR - R -RVF  . . . . . . . . . .  A . . . . .  126  
126 PNTLLGDPAKRLRYFDPLRNEYFFDKNRPSFDGILYYYQSGGRLRRPVNVSLDVFA 181 
141 . . . . . . . . .  P . . . . . . . . . . . . . . . . . . . . . . . .  G . . . . . .  195  
133 . . . . . . . . . . .  H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  188  
133 - -N  . . . .  V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  IgB  
127  -D  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  182 
182 DE IRFYQLGDEAMERFREDEGFIKDEEKPLpRNEFQRQVWLIFEYPESSGSAR~ 237 
196 . . . . . . . . . . . . . . . . . .  E . . . . . . . . . . . . . . . . . . . . .  251  
189 . . . . . . . . . . . . . . . . . .  E . . . . . . . . . . . . . . . . . . . . . . . . . .  244  
189 . . . . . . . . . . . . . . . . . .  E . . . . . . . . . . . . . . . . . . . . . . . . .  244  
183 . . . . . . . . .  L . . . . . . .  E . . . . . . . . . . . . . . . . . . . . . . .  238  
S l  
238  IVSVLVIL IS I ITFCLETLPEFK DERELLRHPPVP HQPPAAPALGAN GSGAV 289 
252 . . . . . . . . . . . . . . . . . . . . .  R . . . . . . . . .  A . . . . . . .  P . . . .  301  
245 . . . . . . . . . . . . . . . . . . .  R . . . . . . . . . . .  P . . . . . .  P - I -  -- 293  
245 . . . . . . . . . . . . . . . .  RV  . . . .  L . . . .  P . . . . . .  P -T -AS  - - 296  
239 . . . . . . . . . . . . . . . . . . . .  R . . . .  V - - -G-P -  - -G  -R -PTQR-R-  289  
S2  
290 APA S GSTVAPLLPRTLADPFF IVETTCVIWFTFELLVRFFACPSKAEFSRNIM 342 
302 M . . . .  P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  G . . . .  355  
294 SG-L  S -P  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  348  
297 LS  - T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  348  
290 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  338  
$3  S4  
343  N I ID IVA IFPYF ITLGTELAEQQPGGGGGGQNGQQAMSLAILRVIRLVRVFRIF~ 398 
356 . . . .  V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  411  
349 - -V  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  402  
349  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  402  
339  - - -V  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  394  
S5  
399 SRHSKGLQILGKTLQASMRELGLL IFFLF IGVILFSSAVYFAEADNQGTHFSSIPD 454 
412 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  467  
403 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  H -S  . . . . . .  458  
403 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  SQF  . . . . .  458  
395 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  E . . . . . . .  450  
86  
455  AFWWAWTMTTVGYGDMRPITVGGKIVGSLCAIAGVLT IALPVPVIVSNFNYFYHR 510 
468 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  523  
459 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  514  
459 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  514  
451 . . . . . . . . . . . . . . . .  V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  506  
511 ETDHEEQAALKEEPGSQSRGTS LDAGGQRKASWSKASLCKAGGSLE TADSVRRG 564 
524 . . . . .  P -V  . . . .  Q -T -Q-PG- -RV- - -V -G-RG-F  . . . . .  T - -N - - -A - - -  577  
515 . . . . . . . . . .  Q -N-R-E  -G- -T  . . . .  V -C  . . . .  F - -T  . . . . .  SS - - I - -  568  
505 . . . . . . . . . .  Q - I  R -E  -G- -T  . . . . .  V -C  . . . .  FH-T -  P - -S  - I - - -  568  
507 . . . . . . . . . . . . .  Q -  - -Q- -G  - S - -P - -T  . . . .  G . . . . .  V - -  N - -GA- -Q  560 
565 SCL  LEKYNLKAKSNVDLRRSLYALCLDTSRETDL*  59S  
578 -P  - -C -V  . . . . . . . . . . . . . . . .  * 612  
569 P - -CH . . . . . . . . . . . . . .  * 603  
569 - -P  - - -CH . . . . . . . . . . . . . . . . .  * 603  
561 -P  - -C  . . . . .  M . . . . . . . . . . . . . .  * 594  
Fig. 1. Amino acid comparison of rabbit Kvl.5 (RBKV1.5), human 
Kvl.5 (HK2), rat Kvl.5 (Kvl), mouse Kvl.5 (mKvl.5) and canine 
Kv1.5 (cKv1.5). Amino acid sequence differences among the five chan- 
nels are indicated. Horizontal dash lines indicate identical amino acids 
among the five channels and blank spaces represent gaps inserted to 
maximize alignment. 
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Fig. 2. RNA blot analysis ofRBKV1.5 mRNA. Poly(A) + RNAs analy- 
sed were as follows: (1) cerebrum, (2) cerebellum, (3) atrium, (4) ventri- 
cle, (5) kidney, (6) liver, (7) lung, (8) skeletal muscle. The positions of 
RNA size markers (BRL) are shown on the right. After hybridization 
with RBKV1.5 probe, the blots were rehybridized with the GAPDH 
probe as control. 
and defolliculated manually with fine forceps. The oocytes were injected 
with the transcribed RNA (40-50 nl) and incubated at 19°C for 24  
days in modified Barth's medium before electrophysiological measure- 
ments. Whole cell currents were recorded by a conventional two-micro- 
electrode voltage clamp method with 3 M KCl-filled electrodes. The 
bath recording solution consisted of 96 mM NaCI, 2 mM KC1, 1.8 mM 
CaCI> 1 mM MgCI> and 5 mM HEPES, pH 7.5 (ND96). All electro- 
physiological measurements were carried out at room tempera- 
lure. 
3. Results and discussion 
3.1. Primary structure of  RBKV1.5 
Nucleotide sequence analysis of RBKV1.5 revealed one long 
open reading frame encoding a protein of  598 amino acid resi- 
dues with calculated Mr of 65,472. The deduced amino acid 
sequence of RBKV1.5 is 83-86% identical to that of  other 
species [10,16-19] (Fig. l). The percentage of identity is not as 
high as it is found in the other members of Shaker K channel 
subfamily. For example, the identity among Kvl .2  channels of 
different species is about 98% and the identity among Kvl .4  
channels of different species is about 95%, The highest identity 
among the Kvl .5 channels is found within the region contain- 
ing the subunit assembly domain and the putative transmem- 
brane segments. Within this region, RBKV1.5 is about 95% 
identical to other Kv 1.5 channels. However, the identity among 
the channels decreases significantly within the amino- and car- 
boxyl-terminal regions, RBKV 1.5 showed only 52-57% identity 
within the amino-terminal region (the residues 1-10b and 
about 70% identity within the carboxyl-terminal region (the 
residues 517-598) to other Kv1.5 channels. The low percentage 
of identity in the amino- and carboxyl-terminal regions may 
reflect the less important role of these regions in forming func- 
tional K + channels. In fact, it is reported that mouse Kvl .5 
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Fig. 3. Volatage-dependent currents recorded from oocytes injected with RBKV1.5 cRNA. (A) Outward currents were elicited by depolarizing voltage 
steps from a holding potential of -80 mV to test potentials ranging from -70 to +40 mV in 10 mV increments. Peak current-voltage relationship 
is shown in (B). (C) Typical current races recorded in the absence (control) and the presence of 0.1 and 1 mM 4-AP. The currents were elicited by 
test pulses to +20 mV from a holding potential of-80 mV. Concentration-response curve for 4-AP is shown in (D) (n = 12). Current amplitudes 
are normalized to the initial values before application of 4-AP. 
isoform in which the first 200 amino acids are deleted can form 
functional K * channel although with less efficacy [18]. It is also 
reported that deletion of 57 carboxyl-terminal residues of HK2 
does not affect the channel function [20]. However, there are 
several potential phosphorylation sites for protein kinase A (the 
residue 565) and protein kinase C (the residues 50, 72, 232, 560 
and 592) in the amino-and carboxyl-termini of RBKV1.5 chan- 
nel. And Kvl type K + channels have been reported to be 
modulated by protein kinase A and protein kinase C [21-27]. 
Therefore, the amino- and carboxyl-termini may be related to 
modulation of the channels by phosphorylation. 
3.2. Distribution of RBKV1.5 mRNA in rabbit tissues 
To investigate he tissue distribution ofRBKV1.5, RNA blot 
analysis was performed with a specific probe for RBKV1.5. The 
major 2.8 kb band was detected in all tissues examined except 
the liver (Fig. 2). The mRNA was expressed at the highest 
abundance in the heart, at high levels in the lung and at mod- 
erate to low levels in the cerebrum, cerebellum, kidney and 
skeletal muscle. In the heart, the primary transcript is almost 
equally abundant in the atrium and ventricle. For human Kvl.5 
channel mRNA (HK2 and fHK mRNA), two different expres- 
sion patterns in the heart are reported although HK2 and fHK 
differ by only 4 amino acids. Whereas HK2 is much more 
abundant in the atrium than in the ventricle, fHK is expressed 
both in the atrium and ventricle at easily detectable l vel [10,16]. 
Therefore, as to the expression pattern in the heart, RBKV1.5 
is similar to fHK. The minor 5.5 kb band was detected in 
cerebrum and cerebellum and the faint 3.1 kb band was de- 
tected in skeletal muscle. No further analysis was made on these 
faint bands. 
3.3. Electrophysiological proper ties of RBKV1.5 
The electrophysiological properties of RBKV1.5 channel 
were examined using Xenopus oocyte expression system. Depo- 
larizing voltage pulses elicited large outward currents in oocytes 
injected with RBKV1.5 cRNA, which showed rapid activation 
and little inactivation during 400 ms pulses (Fig. 3A). With the 
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Fig. 4. Properties of voltage-dependent currents recorded from oocytes injected with RBKV1.5 and rat Kvfll cRNA. (AI Outward currents were 
elicited by depolarizing voltage steps from a holding potential of-80 mV to test potentials ranging from -70 to + 40 mV in 10 mV increments. (B) 
Time course of recovery from inactivation. A control 400-ms pulse to + 20mV from a holding potential of -80mV was given and followed by a second 
identical pulse after an interval of increasing duration at -80 mV. The peak amplitude of the current elicited by the second voltage pulse was expressed 
as a fraction of the corresponding values obtained by control pulse. Fraction recovery was plotted as a funtion of the interpulse interval. (C) 
Steady-state activation curve of RBKV1.5 current (©) and RBKV1.5 + rat Kvfll (e). Peak currents were converted into conductance (G) by the 
formula G = I/( Vm -- Vrev), assuming a reversal potential (Vrev) of -85 mV, where Vm is the membrane voltage of depolarization pulse. The steady-state 
activation curves were fitted to Boltzmann distribution, GIGm~x = 1/[1 + exp(- ( Vm - Id~)/an)], where G~.x is the maximal conductance, Va is the voltage 
for half-activation and an is the slope factor. (D) Steady-state inactivation curve of the current of RBKV1.5 + rat Kvflh Membrane potential was 
stepped from a holding potential of -80 mV to a conditioning prepulse voltage (Vp) ranging from -100 to 0 mV for 400 ms and then to a test pulse 
of + 20 inV. The steady-state inactivation curves were fitted to Boltzmann distribution, I/Im,x = (1 -- ~)/[1 + exp((Vp-Vh)/ah)] +Or, where /max is the 
maximal peak current, V h is the voltage for half-inactivation, a his the slope factor and ~ is the non-inactivating component of the curves. 
larger depolarization (> + 20 mV) partial slow inactivation of 
RBKV1.5 current was observed; less than 4% inactivation at 
+ 20 mV. The activation threshold was about -30 mV and the 
peak current~voltage (I-V) relationship became virtually linear 
above that voltage (Fig. 3B). RBKV1,5 current was sensitive 
to 4-aminopyridine (4-AP) (Fig. 3C) and almost insensitive to 
external tetraethylammonium (TEA). When suppression of the 
peak current in the presence of blockers was measured uring 
the 400 ms depolarizing pulses at + 20 mV, 4-AP blocked the 
current with an ICs0 of 465/,tM (Fig. 3D), but TEA blocked the 
current only by 4% at 10 mM. 
Influence of rat Kvfll subunit on RBKV1.5 current was 
investigated by coexpressing them in Xenopus oocytes. Coex- 
pressed Kvfll caused conversion of RBKV1.5 current from 
delayed rectifier type to rapidly inactivating, A-type, current 
(Fig. 4A). When coexpressed with Kv~l,  RBKV1.5 current 
inactivated rapidly at voltages more positive than 0 mV. The 
current of RBKV1.5 + Kvfll inactivated by 47% within 400 ms 
pulses at + 20 mV, whereas, as described above, less than 4% 
of RBKV1.5 current inactivated at the same voltage. The inac- 
tivating currents were best fitted to a single exponential func- 
tion (at +20 mV, fi = 37.2 _+ 4.46 ms; mean + S.D., n = 5). The 
time constant for recovery from inactivation was 4.87 + 0.36 s 
(n = 7) (Fig. 4B). Recently a third type of K + channel fl subunit 
(hKvfl3) for Kvl  subfamily was cloned from human atrium and 
reported to modulate the kinetics of Kvl .5 channel [12]. Upon 
coexpression with Kvfl3, Kvl .5 current inactivated at very de- 
polarized potentials, more positive than + 30 mV with the faster 
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time constant of about 3.5 ms which is not voltage-dependent. 
Since Kvfl3 is coexpressed with human Kvl .5 [12] and Kvfll is 
coexpressed with rabbit Kvl .5 (this study), we may not be able 
to simply compare the effects of Kvfll and Kvfl3 on Kvl .5 
current. However, it seems that Kvl.5 current inactivates at less 
positive voltage and the inactivation is slower when coex- 
pressed with Kvfll than with Kvfl3. Voltage dependence of 
steady-state activation and inactivation of RBKV1.5 current 
was studied. The activation and inactivation curves were fitted 
to Boltzmann equations as noted in the legend of Fig. 2. Inter- 
estingly, coexpression with Kvfll not only produced inactiva- 
tion of RBKV1.5 current but also affected the steady-state 
activation curve. Coexpression with Kvfll shifted the half-acti- 
vation potential of RBKV1.5 current to the right (RBKV1.5: 
-4.87 + 1.61 mV vs. RBKV1.5 + Kvfll: 2.79 + 0.7 mV) and 
changed the slope factor (RBKV1.5: 10.3 +0.4 mV vs. 
RBKV1.5 + Kvfll: 13.4 + 0.2 mV). This result is not the same 
as that obtained from coexpression of Kvfll and Kvl .4 channel, 
which was described in the first paper on cloning of Kvfl sub- 
units [11]. According to the results, Kvfll does not affect the 
normalized current-voltage relationship when coexpressed 
with amino-terminal deleted Kv1.4 channel. Thus it seems that 
Kvfll subunit interacts with several members of Kvl  subfamily 
and its influence on each Kvl  channel is not completely the 
same. This different effect of Kvfl subunit on different K + 
channels may contribute to the diversity of voltage-dependent 
K + channels. Although any fl subunit has not been isolated 
from rabbit, it is highly possible that RBKV1.5 associates with 
fl subunit(s) contributing to the diversity of voltage-dependent 
K + currents in the native rabbit heart if they are present. De- 
tailed comparison of the properties of RBKV1.5 channel and 
the native rabbit heart K + channels is necessary to reveal the 
physiological importance of the cloned K + channel. 
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